The drug is indicated for patients with moderate or severe persistent asthma who are not adequately controlled with medications based on GINA or NHLBI guidelines.

• 中度或重度的持续形哮喘患者，在无法以GINA或NHLBI准则做有效控制时，即可适用本项药物。